Granite Point Capital
Overview
Granite Point Capital is a Boston-based investment firm founded in 2004 that provides discretionary investment advisory services to private pooled investment vehicles. The firm's investment objective is to maximize returns while preserving capital by pursuing a long/short strategy focused on equities, but also including other publicly traded corporate instruments, private companies, currency, interest rate, futures, and commodity positions.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Teikametrics | Jul 2021 | Series B | Co-investor |
| Receptor Life Sciences | Apr 2022 | Series A Extension | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Granite Point Capital based?
Granite Point Capital is headquartered in Boston, Massachusetts, United States.
When was Granite Point Capital founded?
Granite Point Capital was founded in 2004.
How many portfolio companies does Granite Point Capital have?
Granite Point Capital has 3 portfolio companies in Caplight's dataset.
What are some companies in Granite Point Capital's portfolio?
Portfolio companies visible on Caplight include Teikametrics, Receptor Life Sciences.
What was Granite Point Capital's most recent investment shown here?
Granite Point Capital's most recent investment in this portfolio sample was in Receptor Life Sciences in 2022.
What sectors does Granite Point Capital focus on?
Granite Point Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure.
What company stages does Granite Point Capital focus on?
Granite Point Capital typically invests at the Mid stage.
What is Granite Point Capital's AUM?
Granite Point Capital's assets under management are estimated between $255.0M and $255.0M.